CHOP urges elected officials in Texas to act on blood cancers

The “American Cancer Society” expects that Texas will rank as the third-highest state in leukemia-cases, this year—with a survival-rate of only 66-percent. That’s why the “Coalition of Hematology- and Oncology-Practices” is using September’s observance of “Blood-Cancer Awareness Month” to call on the state’s elected-officials to act. Kathy Oubre [as in “tube”] is the Coalition’s president… “Blood-cancers—such as leukemia, lymphoma, and myeloma—require immediate attention and support. They also affect people of all ages, races, and socioeconomic backgrounds. However, cutting-edge research in immunotherapy, precision medicine, and gene-therapies offer promising avenues—to improve patient-outcomes and quality-of-life. By investing in these areas, we can accelerate both the development and the accessibility of breakthrough treatments—offering hope to those who need it most. The potential exists to transform blood-cancers from life-threatening conditions to manageable chronic-diseases. But, it still requires our collective support.” Among the Coalition’s requests are more funding for clinical trials and vital research-initiatives—along with comprehensive insurance-coverage for blood-cancer treatments.